tirzepatide news https://t.co/QYMeNhMdZk Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease GLP-1 Receptor Agonist Effects standardground Size:1 g

tirzepatide news https://t.co/QYMeNhMdZk Lilly's Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease GLP-1 Receptor Agonist Effects standardground Size:1 g

GLP-1 Receptor Agonist Effects on Lipid and Liver Profiles in Patients with Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis - PMC

They are found in the pancreas (where they regulate insulin secretion), the stomach (where they slow gastric emptying), the brain (where they influence appetite and satiety), and the cardiovascular system (where they affect heart rate and blood pressure)

standardground

Size:1 g

J Pediatr Adolesc Gynecol (2015) 28(5):286–91